InsidersTradesSigma
Track the 바디텍메드 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바디텍메드 has recorded 3 insider filings. Market capitalisation: €243.8bn. The latest transaction was disclosed on 7 April 2026 (Purchase). Among the most active insiders: 최규리. All data is free.
3
Insider Decl.
n/a
Thresholds
€24,744
2 ops.
Buy Volume
n/a
1 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,674 of 29,063 companies
69.3
score / 100
Value63
Quality75
FCF yld-4.9%
Earn yld9.7%
EV/EBITDA6.8x
ROE11%
Gross mgn59%
Net mgn15%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
关于 바디텍메드
巴迪텍메드 是一家专注于医疗器械和诊断测试开发的健康与制药公司。该公司在 XKRX 市场上市。